Guangdong Biolight Meditech Co., Ltd.
300246.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.42B
Close$
$-11.19
191.5% downside
Current Fair Value
191.5% downsideOvervalued by 191.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.42 Billion |
|---|---|
| Enterprise Value | $3.66 Billion |
| Annual dividend | $0.05 |
| Dividend yield | 0.39% |
| Earnings per Share | $-0.26 |
| Beta | 0.9 |
| Outstanding Shares | 261,635,934 |
Return
| Return on Equity | -9.54% |
|---|---|
| Return on Assets | -4.27% |
| Return on Invested Capital | -6.09% |
Valuation & Multiples
| P/E Ratio | -32.83 |
|---|---|
| PEG | -30.73 |
| Price to Sales | 3.06 |
| Price to Book Ratio | 3.06 |
| Enterprise Value to Revenue | 3.36 |
| Enterprise Value to EBIT | -37.39 |
| Enterprise Value to Net Income | -35 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.75 |
Revenue Sources
No data
Next Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$345.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Guangdong Biolight Meditech Co., Ltd.
1,335 employees
CEO: Jinyuan Yan
Guangdong Biolight Meditech Co., Ltd., founded in 1993 and headquartered in Zhuhai, China, operates as a global enterprise. The company is dedicated to the full spectrum of medical technology, encompassing the research, development, comm...